Immediate Simultaneous Bilateral Cataract Surgery
ISBCS
1 other identifier
interventional
100
1 country
1
Brief Summary
To evaluate the safety and efficacy of treating visually significant bilateral cataract with the newer technique of Immediate Simultaneous Bilateral Cataract Surgery (ISBCS) versus the conventional technique of Delayed Sequential Bilateral Cataract Surgery (DSBCS) in a select patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 18, 2013
CompletedFirst Posted
Study publicly available on registry
April 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedApril 28, 2022
April 1, 2022
9 years
April 18, 2013
April 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity
Best uncorrected and best spectacle corrected post-operative visual acuity
3 weeks
Secondary Outcomes (1)
Recovery time and number of post-operative visits
6 months
Study Arms (2)
ISBCS
EXPERIMENTALImmediate Simultaneous Bilateral Cataract Surgery
DSBCS
ACTIVE COMPARATORDelayed Sequential Bilateral Cataract Surgery
Interventions
Eligibility Criteria
You may qualify if:
- Age 30-100
- Candidate for topical anesthesia
- Signed the informed consents
You may not qualify if:
- Allergies to medications used in study
- Cannot have topical anesthesia
- Unwilling to participate in research trial
- Have any other significant ocular comorbidities
- Have known systemic immuno-compromised state
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Panhandle Eye Group
Amarillo, Texas, 79106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 18, 2013
First Posted
April 29, 2013
Study Start
April 1, 2013
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
April 28, 2022
Record last verified: 2022-04